Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H44O |
Molecular Weight | 384.6377 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)CCC3=C)[C@H](C)CCCC(C)C
InChI
InChIKey=QYSXJUFSXHHAJI-YRZJJWOYSA-N
InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1
Molecular Formula | C27H44O |
Molecular Weight | 384.6377 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 2 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:56:34 UTC 2023
by
admin
on
Sat Dec 16 17:56:34 UTC 2023
|
Record UNII |
1C6V77QF41
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
M05BB03
Created by
admin on Sat Dec 16 17:56:36 UTC 2023 , Edited by admin on Sat Dec 16 17:56:36 UTC 2023
|
||
|
NCI_THESAURUS |
C941
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-ATC |
M05BB05
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ADROVANCE (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
FOSAVANCE (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
LOINC |
33958-0
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
DSLD |
207 (Number of products:385)
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-ATC |
M05BB08
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-VATC |
QM05BB03
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-VATC |
QM05BX53
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
CFR |
21 CFR 172.380
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-ATC |
M05BX53
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
LOINC |
87671-4
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
VANTAVO (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
LOINC |
1990-1
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
FDA ORPHAN DRUG |
348111
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
27
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
FDA ORPHAN DRUG |
342911
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-VATC |
QM05BB05
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
NDF-RT |
N0000006277
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-ATC |
A11CC05
Created by
admin on Sat Dec 16 17:56:36 UTC 2023 , Edited by admin on Sat Dec 16 17:56:36 UTC 2023
|
||
|
WHO-ATC |
A11CC55
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
EPA PESTICIDE CODE |
202901
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
DSLD |
2297 (Number of products:7402)
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
NDF-RT |
N0000175952
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-ATC |
M05BB04
Created by
admin on Sat Dec 16 17:56:36 UTC 2023 , Edited by admin on Sat Dec 16 17:56:36 UTC 2023
|
||
|
WHO-VATC |
QM05BB04
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-VATC |
QA11CC05
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
LIVERTOX |
NBK548094
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
||
|
WHO-ATC |
M05BB07
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB00169
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
CHEMBL1042
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
1244014
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
ALTERNATIVE | |||
|
2840
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
1C6V77QF41
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
CHOLECALCIFEROL
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odourless.Solubility: Practically insoluble in water; soluble in ethanol (~750 g/l) TS, ether R.Category: Vitamin, antirachitic.Storage: Colecalciferol should be kept in a hermetically closed container, in an inert atmosphere, protected from light and storedat a temperature between 2? and 8?C.Additional information: Even in the absence of light, Colecalciferol is gradually degraded on exposure to a humid atmosphere, thedecomposition being faster at higher temperatures. | ||
|
C48194
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
200-673-2
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
5280795
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
820
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
1497
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
D002762
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
CHOLECALCIFEROL
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
1131009
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
28940
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
cholecalciferol
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
100000092724
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
m11486
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID6026294
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
2747
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
67-97-0
Created by
admin on Sat Dec 16 17:56:36 UTC 2023 , Edited by admin on Sat Dec 16 17:56:36 UTC 2023
|
PRIMARY | |||
|
SUB06794MIG
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
2418
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
1C6V77QF41
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY | |||
|
375571
Created by
admin on Sat Dec 16 17:56:37 UTC 2023 , Edited by admin on Sat Dec 16 17:56:37 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
DERIVATIVE -> PARENT |
|
||
|
EPIMER -> DIASTEREOISOMER |
HYDROXYL GROUP IN R CONFIGURATION COMPARED TO CHOLECALCIFEROL
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
DERIVATIVE -> PARENT |
|
||
|
DERIVATIVE -> PARENT |
|
||
|
DERIVATIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
||
|
METABOLITE ACTIVE -> PRODRUG |
The conversion of calcidiol to calcitriol is catalyzed by the enzyme 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1).
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
EPIMER OF 7-DEHYDROCHOLESTEROL [EP IMPURITYB]
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|